Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients

NCT00260234 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Stopped in December 2007

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: Allogeneic Cultured Islet Cells (human); Encapsulated

Sponsor

Novocell

Collaborators

[object Object]
[object Object]